‘Leukemia-On-A-Chip’ Could Transform CAR T Blood Cancer Treatments

Chimeric antigen receptor (CAR) T cell therapy represents a breakthrough in cancer treatment. By harnessing the body’s immune system, CAR T therapy provides a powerful, personalized treatment option that can be particularly effective for treating blood cancers like leukemia — potentially offering patients a second chance at life when other treatments have failed.